IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe
Letters to the Editor John Galloway, G. Blackman
  • 1 April 1994
Experimental and Clinical Pharmacology

Expiry dates

Michael Dawson
  • 1 April 1994
Letters to the Editor

Antiviral drugs

Len Moaven, Dr A. Street
  • 1 April 1994
Feature

Your questions to the PBAC

Margaret Beavis
  • 1 April 1994
Experimental and Clinical Pharmacology

Dopamine - clinical applications ii. psychiatry

Nicholas A. Keks, David L. Copolov
  • 1 April 1994
Article

Product information: what does it define?

M.L. Mashford
  • 1 April 1994
Letters to the Editor

MAO inhibitors

J.W.G. Tiller, P.K. Gillman
  • 1 April 1994
Article

Contents of toothpaste - safety implications

Eric C. Reynolds
  • 1 April 1994
Experimental and Clinical Pharmacology

Dopamine: clinical applications iii. cardiovascular

Barry P. McGrath, Xhi Qin Wang
  • 1 April 1994
Article

The non-pharmacological treatment of back pain

John E. Murtagh
  • 1 April 1994
Letters to the Editor

MAO inhibitors in psychiatry

Dr Chris Cantor, Associate Professor L. Evans
  • 1 April 1994
NEW DRUGS
Felodipine
  • 1 April 1994
Hexamethylmelamine
  • 1 April 1994
Lenograstim
  • 1 April 1994
Flupenthixol decanoate
  • 1 April 1994
Isosorbide dinitrate
  • 1 April 1994
Ciprofloxacin
  • 1 April 1994
Gadodiamide
  • 1 April 1994
Glipizide
  • 1 April 1994
Midazolam
  • 1 April 1994
Nafarelin acetate
  • 1 April 1994
Isotretinoin
  • 1 April 1994

IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe